Llwytho...
Surfactants in the Management of Respiratory Distress Syndrome in Extremely Premature Infants
Respiratory distress syndrome (RDS) is primarily due to decreased production of pulmonary surfactant, and it is associated with significant neonatal morbidity and mortality. Exogenous pulmonary surfactant therapy is currently the treatment of choice for RDS, as it demonstrates the best clinical and...
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Pediatric Pharmacy Advocacy Group
2006
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3468090/ https://ncbi.nlm.nih.gov/pubmed/23118650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-11.3.132 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|